Demis Hassabis & Isomorphic Labs
3 shared events · Importance 3 · Last updated Aug 07, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Demis Hassabis: Hassabis transitions from CEO to Chair of Alphabet Inc. — Google DeepMind and Chief Scientist of Alphabet, focusing on AGI strategy. He remains a key figure, but his reduced operational role may affect DeepMind's direction.
Isomorphic Labs: Isomorphic Labs, the AI drug discovery company, remains under Hassabis's leadership. He will spend more time there, potentially accelerating its work in biomedical applications.
Aug 05, 2026 · 86 articles
Tech
Demis Hassabis: Demis Hassabis, CEO of Alphabet Inc. — Google DeepMind and Nobel laureate, remains at the company but oversees the strategic shift away from the AlphaFold model.
Isomorphic Labs: Isomorphic Labs, Alphabet's drug discovery spinout, gains some former AlphaFold researchers, potentially benefiting from their expertise.
Jul 29, 2026 · 7 articles
Business
Demis Hassabis: Demis Hassabis, CEO of Alphabet Inc. — Google DeepMind, acknowledges the competitive AI talent market but maintains confidence in Alphabet Inc.'s ability to attract and retain top talent, attempting to reassure investors.
Isomorphic Labs: Some members of John Jumper's protein-folding research team have moved to Isomorphic Labs, an Alphabet spinout, indicating internal talent shifts within Alphabet's AI ecosystem.
Jun 24, 2026 · 14 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Demis Hassabis and Isomorphic Labs interact across events, view sentiment trends, and discover connected entities.
Open Dashboard